Eastgate Biotech Corp.
ETBI · OTC
9/30/2017 | 6/30/2017 | 3/31/2017 | 12/31/2016 | |
|---|---|---|---|---|
| Market Cap | $1,223 | $919 | $13,677 | $9,753 |
| - Cash | $5 | $79 | $9 | -$50 |
| + Debt | $3,079 | $2,384 | $1,826 | $1,716 |
| Enterprise Value | $4,297 | $3,224 | $15,493 | $11,520 |
| Revenue | $23 | $115 | $0 | -$94 |
| % Growth | -79.8% | – | 100% | – |
| Gross Profit | -$69 | $58 | $0 | -$80 |
| % Margin | -299.1% | 50.3% | – | 85.1% |
| EBITDA | -$1,721 | $0 | -$915 | -$891 |
| % Margin | -7,439.6% | 0% | – | 953.2% |
| Net Income | -$1,633 | -$715 | -$952 | -$935 |
| % Margin | -7,057.2% | -624.3% | – | 999.2% |
| EPS Diluted | -0.002 | -0.001 | -0.003 | -0.003 |
| % Growth | -25% | 60% | 3.2% | – |
| Operating Cash Flow | -$1,331 | -$131 | -$121 | -$168 |
| Capital Expenditures | -$0 | $0 | $0 | $0 |
| Free Cash Flow | -$1,331 | -$131 | -$121 | -$168 |